Lupin appoints Fabrice Egros as President of Asia Pacific business

NEW DELHI: Drug major Lupin today said it has appointed Fabrice Egros as President, Asia Pacific and Japan.

Egros, based in Tokyo, will be responsible for the company's growth and development across key markets such as Japan, Australia, the Philippines, South East Asia and new markets in rest of the ASEAN region.

"His deep knowledge of the Asia-Pacific markets will be invaluable as we consolidate and grow our business in the region," Lupin Ltd, Managing Director, Nilesh Gupta said in a statement.

This region is the third largest revenue contributor for the company globally, he added.

"I believe that Fabrice's experience will help Lupin achieve its growth plans for the Asia Pacific region, and help us scale the business to new heights," Gupta said.

Egros has over 25 years of experience in the global pharmaceutical industry, having worked in leadership roles.

Prior to joining Lupin, Egros was with NovaMedica where he was the Deputy CEO/COO and instrumental in setting up an integrated new pharmaceutical business.

Before NovaMedica, he has worked with global majors such as UCB, Sanofi and Parke Davis in various global and regional capacities.